Bone Morphogenetic Protein-4-induced Epithelial-Mesenchymal Transition and Invasiveness Through Smad1-mediated Signal Pathway in Squamous Cell Carcinoma of the Head and Neck

被引:32
|
作者
Xu, Ting [1 ,2 ]
Yu, Chang-yun [1 ]
Sun, Jin-jie [1 ]
Liu, Yong [1 ]
Wang, Xing-wei [1 ]
Pi, Lei-ming [1 ]
Tian, Yong-quan [1 ]
Zhang, Xin [1 ]
机构
[1] Cent S Univ, Dept Otolaryngol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
[2] Nanjing Med Univ, Peoples Hosp Wuxi 2, Dept Otolaryngol, Wuxi, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
Bone morphogenetic protein-4; Squamous cell carcinoma of the head and neck; Epithelial-mesenchymal transition; Invasiveness; TRANSFORMING GROWTH-FACTOR-BETA-1; CANCER STATISTICS; OVARIAN-CANCER; TGF-BETA; METASTASIS; EXPRESSION; INVASION; INHIBITION; TGF-BETA-1; PROTEINS;
D O I
10.1016/j.arcmed.2011.03.003
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background and Aims. Bone morphogenetic proteins (BMPs) have recently been shown to be involved in the genesis and progression of a wide variety of carcinomas. The present study was undertaken to estimate the effect of BMP-4 on squamous cell carcinoma of the head and neck (SCCHN) in tissue and cell levels. Methods. In this study, immunohistochemistry, Western blotting and RT-PCR were utilized to detect the expression of BMP-4, Smad1 and phosphorylated Smad1 in SCCHN tissues or SCCHN cell lines. Those three proteins in tissues were further correlated with prognosis of SCCHN by Kaplan-Meier analysis. The epithelial-mesenchymal transition (EMT)-associated changes in SCCHN cells were detected after stimulation by human BMP-4 recombinant protein and knockdown of Smad1 gene. Meanwhile, the effect on invasiveness and migration was evaluated by invasion and scratch assays, respectively. Results. BMP-4 and p-Smad1 protein were overexpressed in SCCHN tissues with cervical lymph node metastasis, which was significantly higher than those without metastasis. The expression of BMP-4 and p-Smad1 protein was negatively correlated with the prognosis of SCCHN. BMP-4 promoted the invasiveness and migration through EMT, which was demonstrated by morphological alterations, loss of E-cadherin, increase of vimentin and activation of the Smad1 signal pathway. Knockdown of Smad 1 expression suppressed BMP-4 induced EMT in both cell lines and weakened the invasiveness and migration of Tu686 and Tu212 in vitro. Conclusions. Our results demonstrate that BMP-4 protein may contribute to the malignant metastasis of SCCHN, which presents as a novel prognostic marker and a potential therapeutic target for patients with SCCHN. (C) 2011 IMSS. Published by Elsevier Inc.
引用
收藏
页码:128 / 137
页数:10
相关论文
共 50 条
  • [21] Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
    Ma, Wei
    Liao, Yiqun
    Gao, Ziwen
    Zhu, Wenyan
    Liu, Jianbing
    She, Wandong
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [22] TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma
    Zhang, Wei
    Li, Jin
    Wu, Yaping
    Ge, Han
    Song, Yue
    Wang, Dongmiao
    Yuan, Hua
    Jiang, Hongbing
    Wang, Yanling
    Cheng, Jie
    CANCER CELL INTERNATIONAL, 2018, 18
  • [23] Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
    Yuhong Huang
    Han Liu
    Bo Liu
    Xiaoyan Chen
    Danya Li
    Junyuan Xue
    Nan Li
    Lei Zhu
    Liu Yang
    Jing Xiao
    Chao Liu
    BMC Medical Genomics, 17
  • [24] TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma
    Wei Zhang
    Jin Li
    Yaping Wu
    Han Ge
    Yue Song
    Dongmiao Wang
    Hua Yuan
    Hongbing Jiang
    Yanling Wang
    Jie Cheng
    Cancer Cell International, 18
  • [25] KDM5B promotes metastasis and epithelial-mesenchymal transition via Wnt/β-catenin pathway in squamous cell carcinoma of the head and neck
    Yuan, Wenhui
    Hu, Junli
    Wang, Mengshu
    Li, Guo
    Lu, Shanhong
    Qiu, Yuanzheng
    Liu, Chao
    Liu, Yong
    MOLECULAR CARCINOGENESIS, 2024, 63 (05) : 885 - 896
  • [26] Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
    Huang, Yuhong
    Liu, Han
    Liu, Bo
    Chen, Xiaoyan
    Li, Danya
    Xue, Junyuan
    Li, Nan
    Zhu, Lei
    Yang, Liu
    Xiao, Jing
    Liu, Chao
    BMC MEDICAL GENOMICS, 2024, 17 (01)
  • [27] Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma
    Cheng, Haixia
    Fertig, Elana J.
    Ozawa, Hiroyuki
    Hatakeyama, Hiromitsu
    Howard, Jason D.
    Perez, Jimena
    Considine, Michael
    Thakar, Manjusha
    Ranaweera, Ruchira
    Krigsfeld, Gabriel
    Chung, Christine H.
    CANCER BIOLOGY & THERAPY, 2015, 16 (08) : 1252 - 1258
  • [28] Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma
    Tada, Hiroe
    Takahashi, Hideyuki
    Ida, Shota
    Nagata, Yurino
    Chikamatsu, Kazuaki
    ANTICANCER RESEARCH, 2020, 40 (06) : 3559 - 3564
  • [29] Induction of epithelial-mesenchymal transition (EMT) and Gli1 expression in head and neck squamous cell carcinoma (HNSCC) spheroid cultures
    Essid, Nesrine
    Chambard, Jean Claude
    Elgaaied, Amel Benammar
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2018, 18 (04) : 336 - 346
  • [30] CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis
    Zhang, Chen
    Qiao, Hongjiang
    Guo, Weinan
    Liu, Yuan
    Yang, Luting
    Liu, Yufeng
    Jin, Boquan
    Fu, Meng
    Wang, Gang
    Li, Wei
    CANCER LETTERS, 2019, 455 : 1 - 13